AMANDA GETT-CHAPEROT
Partner at Seventure Partners
About
Amanda Gett-Chaperot serves as a Partner at Seventure Partners, a prominent European venture capital firm. She is dedicated to identifying and supporting groundbreaking early-stage companies across the life sciences, digital health, and sustainable food technology sectors. Her expertise lies in guiding innovative startups from their initial seed rounds through Series A funding, fostering significant growth and market disruption.
Experience
Deep Dive
Amanda Gett-Chaperot stands as a distinguished Partner at Seventure Partners, a leading European venture capital firm renowned for its commitment to innovation. In her pivotal role, Amanda is instrumental in shaping the future of early-stage companies, particularly within the dynamic fields of life sciences, digital health, and sustainable food technology. Her work at Seventure Partners involves a comprehensive approach, from meticulously sourcing promising startups to conducting thorough due diligence and actively managing portfolio companies to ensure their success.
Her investment focus areas are strategically aligned with global challenges and emerging opportunities. Amanda Gett-Chaperot has a keen eye for disruptive technologies in life sciences, encompassing biotechnology, medical technology, and pharmaceuticals. She is also a strong proponent of digital health solutions that leverage technology to improve patient outcomes and healthcare efficiency. Furthermore, her interest extends to sustainable food technology and the burgeoning field of the microbiome, recognizing their potential to revolutionize health and environmental sustainability. Amanda's investment philosophy centers on backing visionary founders with robust scientific foundations and scalable business models, providing not just capital but also strategic guidance and mentorship.
Amanda's career background is marked by a deep understanding of both scientific innovation and venture capital dynamics. Prior to her role as Partner at Seventure Partners, her professional journey likely included significant experience in scientific research, business development within the biotech or pharmaceutical industry, or previous roles in investment firms. This diverse background equips her with the unique ability to critically evaluate complex scientific propositions while also assessing market potential and commercial viability. Her expertise is invaluable in navigating the intricate landscape of early-stage funding, helping companies transition from groundbreaking ideas to market-ready solutions.
At Seventure Partners, Amanda Gett-Chaperot contributes significantly to the firm's impressive track record of identifying and nurturing high-growth ventures. While specific individual investments are often part of a broader team effort, her influence is evident in the firm's robust portfolio within her areas of specialization. She plays a crucial role in supporting companies through critical growth phases, helping them secure subsequent funding rounds, expand their teams, and achieve key milestones. Her dedication to fostering innovation and her strategic insights make her a highly respected figure in the European venture capital ecosystem, driving forward the next generation of life sciences and technology leaders.
Frequently Asked Questions
Who is Amanda Gett-Chaperot?
Amanda Gett-Chaperot is a Partner at Seventure Partners, a leading European venture capital firm. She is known for her expertise in early-stage investments within the life sciences, digital health, and sustainable food technology sectors.
What does Amanda Gett-Chaperot invest in?
Amanda Gett-Chaperot primarily invests in early-stage companies focused on life sciences, including biotechnology and medical technology, as well as digital health and sustainable food technology, often with a particular interest in the microbiome.
Where does Amanda Gett-Chaperot work?
Amanda Gett-Chaperot works as a Partner at Seventure Partners, a prominent venture capital firm with offices across Europe, including Paris, Munich, and London.